- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03686137
Institut Paoli Calmettes Hepatic Surgery Database (BDD CHIRHEP)
September 25, 2018 updated by: Institut Paoli-Calmettes
Database of patients who undergo hepatic surgery for: benign diseases, primary or secondary liver cancer at Institut Paoli-Calmettes
Study Overview
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sandra Cournier
- Phone Number: +33491223778
- Email: drci.up@ipc.unicancer.fr
Study Locations
-
-
Bouches Du Rhone
-
Marseille, Bouches Du Rhone, France, 13009
- Recruiting
- Institut Paoli Calmettes
-
Principal Investigator:
- Ugo Marchese
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient treated at Institut Paoli-Calmettes who undergo liver surgery for benign liver tumor, primary or secondary liver cancer
Description
Inclusion Criteria:
- Patient undergoing liver surgery for benign liver tumor, primary or secondary liver cancer
Exclusion Criteria:
- Patient refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Institut Paoli-Calmettes patients undergoing liver surgery
|
Colelction of pre-operative, surgical and post-surgical data
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Epidemiological description
Time Frame: 5 years
|
Epidemiological description of the patients who undergo hepatic surgery at Institut Paoli-Calmettes
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ugo Marchese, Institut Paoli-Calmettes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 6, 2017
Primary Completion (Anticipated)
November 1, 2030
Study Completion (Anticipated)
November 1, 2030
Study Registration Dates
First Submitted
September 25, 2018
First Submitted That Met QC Criteria
September 25, 2018
First Posted (Actual)
September 26, 2018
Study Record Updates
Last Update Posted (Actual)
September 26, 2018
Last Update Submitted That Met QC Criteria
September 25, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- BDD CHIRHEP-IPC 2017-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Surgery
-
Centre hospitalier de l'Université de Montréal...University of Alberta; McGill University Health Centre/Research Institute of... and other collaboratorsCompletedIntraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation (ELIPTO-2)Liver Diseases | Liver Failure | Surgery | Surgery--Complications | Transplant; Failure, LiverCanada
-
Erasme University HospitalBicetre HospitalCompleted
-
Zhejiang Cancer HospitalCompleted
-
Maastricht University Medical CenterKing's College Hospital NHS Trust; Oslo University Hospital; Federico II University and other collaboratorsActive, not recruitingLiver SurgeryUnited Kingdom, Netherlands, Belgium, Italy, Norway, Russian Federation
-
University Hospital, AngersUnknown
-
Instituto de Investigacion Sanitaria La FeUnknown
-
University of ZurichUnknownMajor Liver SurgerySwitzerland
-
Aretaieio HospitalUnknownLiver Surgery | ApoptosisGreece
-
Mayo ClinicEnrolling by invitationLiver Transplant SurgeryUnited States
-
University Hospital, GhentMedtronicCompletedLaparoscopic Liver SurgeryBelgium
Clinical Trials on Data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance